Get the Stockscreener App
1.90
4.52%
-0.09
Exicure Inc stock is traded at $1.90, with a volume of 20,808.
It is down -4.52% in the last 24 hours and down -34.93% over the past month.
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
See More
Previous Close:
$1.99
Open:
$2.01
24h Volume:
20,808
Relative Volume:
0.84
Market Cap:
$12.11M
Revenue:
$500.00K
Net Income/Loss:
$-9.78M
P/E Ratio:
-1.2322
EPS:
-1.5419
Net Cash Flow:
$-8.10M
1W Performance:
-8.65%
1M Performance:
-34.93%
6M Performance:
-67.35%
1Y Performance:
-70.63%
1-Day Range:
$1.89
$2.035
1-Week Range:
$1.88
$2.0999
52-Week Range:
$1.71
$9.50
Exicure Inc Stock (XCUR) Company Profile
Name
Exicure Inc
Sector
Industry
Phone
847-673-1707
Address
2430 N. HALSTED ST., CHICAGO, IL
Compare XCUR vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.625 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.49 | 2.97B | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
20.01 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.20 | 349.09M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
4.72 | 358.07M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
47.37 | 0 | 0 | 0 | 0 | 0.00 |
Exicure Inc Stock (XCUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-21 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Dec-18-20 | Initiated | BMO Capital Markets | Outperform |
| Nov-20-19 | Initiated | Guggenheim | Buy |
Exicure Inc Stock (XCUR) Latest News
Exicure stock holds its line. Company context stays front and center. - AD HOC NEWS
Non-controlling/minority interest of Exicure, Inc. – DUS:2H0 - TradingView
Enterprise value to EBITDA forward of Exicure, Inc. – NASDAQ:XCUR - TradingView
Exicure stock leans on its cash position. Nasdaq listing keeps it visible. - AD HOC NEWS
(XCUR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Exicure refreshes board with new independent directors - TipRanks
New directors join Exicure (NASDAQ: XCUR) board as compensation committee forms - Stock Titan
Exicure announces board changes, adds two new directors By Investing.com - Investing.com Nigeria
Exicure announces board changes, adds two new directors - Investing.com
Press Release: Exicure Announces Board and Committee Changes - Moomoo
Exicure Announces Board and Committee Changes - The Manila Times
Exicure expands board to 6, names 2 new directors - Stock Titan
Price to book forward of Exicure, Inc. – NASDAQ:XCUR - TradingView
Enterprise value to revenue forward of Exicure, Inc. – NASDAQ:XCUR - TradingView
Price to earnings forward of Exicure, Inc. – NASDAQ:XCUR - TradingView
Price to sales forward of Exicure, Inc. – NASDAQ:XCUR - TradingView
Enterprise value to EBIT forward of Exicure, Inc. – NASDAQ:XCUR - TradingView
Exicure, Inc. Actuals & Estimates (NASDAQ:XCUR) - TradingView
Exicure, Inc. Actuals & Estimates (SWB:2H0) - TradingView
Exicure Inc (XCUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Exicure Q2 2022 Earnings: EPS Misses Estimates by 35.6% as Stock Gains 18.6%EPS Growth Report - dars.gov.et
Exicure StockThursday technicals and trading picture - AD HOC NEWS
Total equity of Exicure, Inc. – DUS:2H0 - TradingView
Exicure, Inc. Balance Sheet – DUS:2H0 - TradingView
Cash from operating activities of Exicure, Inc. – DUS:2H0 - TradingView
Exicure Inc (XCUR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Exicure Inc (XCUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Exicure Inc (XCUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Exicure Inc (XCUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enterprise value of Exicure, Inc. – DUS:2H0 - TradingView
Exicure Inc (XCUR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Exicure Inc (XCUR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Exicure Inc (XCUR) Institutional Confidence - TradingKey
Exicure Inc (XCUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Exicure Inc. (XCUR) Plunges 22% as Selling Pressure Mounts – Key Support in FocusALMA Signal - newsline.com
XCUR Q2 2022 Earnings: EPS Misses Estimates as Exicure Reports No Revenue and Continues R&D FocusOne-Time Loss Impact - dars.gov.et
XCUR Q2 2022 Earnings: Wider-than-Expected Loss with No Reported RevenueRevenue Warning Signal - newsline.com
Exicure Inc. Q2 2022 Earnings: Significant EPS Miss Amidst No RevenueGAAP Earnings Report - newsline.com
Exicure receives Nasdaq notice for falling below $2.5M equity requirement, plans to regain compliance. - Pluang
Exicure receives Nasdaq notice for equity deficiency - Investing.com
Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement - The Manila Times
Exicure receives Nasdaq notice for equity deficiency By Investing.com - Investing.com Canada
XCUR Q2 2022 Earnings: Wider-Than-Expected Loss on No RevenueAnalyst Drop Coverage - newsline.com
Exicure faces Nasdaq listing deadline as equity sits at $2.1M vs $2.5M - Stock Titan
Exicure Inc stock (US30205M1027): biotech penny stock seeks direction after strategic shifts - AD HOC NEWS
XCUR Technical Analysis | Trend, Signals & Chart Patterns | EXICURE INC (NASDAQ:XCUR) - ChartMill
Exicure Inc. (XCUR) Q2 2022 Earnings: Wider-Than-Expected Loss Amid Operational ChallengesQuarterly Earnings - dars.gov.et
Exicure Regains Nasdaq Compliance After Late Quarterly Filing - The Globe and Mail
Exicure Announces Receipt Of Nasdaq Delinquency Notice And Filing Of Form 10-Q - TradingView
Exicure receives Nasdaq notice for delayed quarterly filing By Investing.com - Investing.com South Africa
Exicure receives Nasdaq notice for delayed quarterly filing - Investing.com
Exicure Inc Stock (XCUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Exicure Inc Stock (XCUR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Exicure HiTron Inc. | 10% Owner |
Jan 16 '26 |
Sale |
4.50 |
734,747 |
3,306,362 |
1,857,314 |
| Exicure HiTron Inc. | 10% Owner |
Jan 07 '26 |
Sale |
4.50 |
741,272 |
3,335,724 |
2,592,061 |
| SANGSANGIN INVESTMENT & SECURI | 10% Owner |
Dec 08 '25 |
Sale |
8.71 |
433,332 |
3,774,322 |
0 |
1.17%
2.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):